Dermatomyositis is associated with an increased risk of cardiovascular and cerebrovascular events: A Taiwanese population-based longitudinal follow-up study

British Journal of Dermatology

Volumn 168, Issue 5, 2013, Pages 1054-1059

  Lai, Y T ^a,b   Dai, Y S ^b   Yen, M F ^c   Chen, L S ^c   Chen, H H ^d   Cooper, R G ^e   Pan, S L ^b  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; COHORT ANALYSIS; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DERMATOMYOSITIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURVIVAL RATE; TAIWAN;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; DERMATOMYOSITIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RISK FACTORS; STROKE; TAIWAN;

EID: 84876968053     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12245     Document Type: Article

References (32)

1. Frostegard J,. Atherosclerosis in patients with autoimmune disorders. Arterioscler Thromb Vasc Biol 2005; 25: 1776-85.
2. Van Doornum S, McColl G, Wicks IP,. Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum 2002; 46: 862-73.
3. Maradit-Kremers H, Nicola PJ, Crowson CS, et al. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005; 52: 722-32.
4. Sherer Y, Cerinic MM, Bartoli F, et al. Early atherosclerosis and autoantibodies to heat-shock proteins and oxidized LDL in systemic sclerosis. Ann N Y Acad Sci 2007; 1108: 259-67.
5. Seyahi E, Ugurlu S, Cumali R, et al. Atherosclerosis in Takayasu arteritis. Ann Rheum Dis 2006; 65: 1202-7.
6. Nadareishvili Z, Michaud K, Hallenbeck JM, Wolfe F,. Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study. Arthritis Rheum 2008; 59: 1090-6.
7. Chiu CC, Huang CC, Chan WL, et al. Increased risk of ischemic stroke in patients with systemic lupus erythematosus: a nationwide population-based study. Intern Med 2012; 51: 17-21.
8. Bessant R, Hingorani A, Patel L, et al. Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus. Rheumatology (Oxford) 2004; 43: 924-9.
9. Radovits BJ, Popa-Diaconu DA, Popa C, et al. Disease activity as a risk factor for myocardial infarction in rheumatoid arthritis. Ann Rheum Dis 2009; 68: 1271-6.
10. Tisseverasinghe A, Bernatsky S, Pineau CA,. Arterial events in persons with dermatomyositis and polymyositis. J Rheumatol 2009; 36: 1943-6.
11. Silver RM, Maricq HR,. Childhood dermatomyositis: serial microvascular studies. Pediatrics 1989; 83: 278-83.
12. Emslie-Smith AM, Engel AG,. Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol 1990; 27: 343-56.
13. De Visser M, Emslie-Smith AM, Engel AG,. Early ultrastructural alterations in adult dermatomyositis. Capillary abnormalities precede other structural changes in muscle. J Neurol Sci 1989; 94: 181-92.
14. Regan M, Haque U, Pomper M, et al. Central nervous system vasculitis as a complication of refractory dermatomyositis. J Rheumatol 2001; 28: 207-11.
15. De Vries S,. Retinopathy in dermatomyositis. AMA Arch Ophthalmol 1951; 46: 432-5.
16. Jalleh RP, Swift RI, Sundaresan M, et al. Necrotising testicular vasculitis associated with dermatomyositis. Br J Urol 1990; 66: 660.
17. Matsuda Y, Harigai M, Nakajima H, et al. Dermatomyositis with splenic and renal infarctions during corticosteroid therapy. Intern Med 2000; 39: 512-16.
18. Haupt HM, Hutchins GM,. The heart and cardiac conduction system in polymyositis-dermatomyositis: a clinicopathologic study of 16 autopsied patients. Am J Cardiol 1982; 50: 998-1006.
19. Denbow CE, Lie JT, Tancredi RG, Bunch TW,. Cardiac involvement in polymyositis: a clinicopathologic study of 20 autopsied patients. Arthritis Rheum 1979; 22: 1088-92.
20. Gonzalez-Lopez L, Gamez-Nava JI, Sanchez L, et al. Cardiac manifestations in dermato-polymyositis. Clin Exp Rheumatol 1996; 14: 373-9.
21. Sholter DE, Armstrong PW,. Adverse effects of corticosteroids on the cardiovascular system. Can J Cardiol 2000; 16: 505-11.
22. Panoulas VF, Douglas KM, Stavropoulos-Kalinoglou A, et al. Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis. Rheumatology (Oxford) 2008; 47: 72-5.
23. Huiart L, Ernst P, Ranouil X, Suissa S,. Low-dose inhaled corticosteroids and the risk of acute myocardial infarction in COPD. Eur Respir J 2005; 25: 634-9.
24. Voisard R, Seitzer U, Baur R, et al. Corticosteroid agents inhibit proliferation of smooth muscle cells from human atherosclerotic arteries in vitro. Int J Cardiol 1994; 43: 257-67.
25. Wei L, MacDonald TM, Walker BR,. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Ann Intern Med 2004; 141: 764-70.
26. Souverein PC, Berard A, Van Staa TP, et al. Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart 2004; 90: 859-65.
27. Naranjo A, Sokka T, Descalzo MA, et al. Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study. Arthritis Res Ther 2008; 10: R30.
28. Maradit-Kremers H, Reinalda MS, Crowson CS, et al. Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica. Arthritis Rheum 2007; 57: 279-86.
29. Toms TE, Panoulas VF, Douglas KM, et al. Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther 2008; 10: R145.
30. Avina-Zubieta JA, Abrahamowicz M, Choi HK, et al. Risk of cerebrovascular disease associated with the use of glucocorticoids in patients with incident rheumatoid arthritis: a population-based study. Ann Rheum Dis 2011; 70: 990-5.
31. Wen CP, Tsai SP, Chung WS,. A 10-year experience with universal health insurance in Taiwan: measuring changes in health and health disparity. Ann Intern Med 2008; 148: 258-67.
32. Huang YL, Chen YJ, Lin MW, et al. Malignancies associated with dermatomyositis and polymyositis in Taiwan: a nationwide population-based study. Br J Dermatol 2009; 161: 854-60.